ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $291,000 | -9.3% | 23,354 | -0.3% | 0.00% | -33.3% |
| Q3 2016 | $321,000 | +85.5% | 23,429 | 0.0% | 0.00% | +200.0% |
| Q2 2016 | $173,000 | -6.0% | 23,429 | -18.5% | 0.00% | -50.0% |
| Q1 2016 | $184,000 | +2.2% | 28,732 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $180,000 | -8.2% | 28,732 | -14.4% | 0.00% | 0.0% |
| Q3 2015 | $196,000 | -21.9% | 33,582 | +10.5% | 0.00% | 0.0% |
| Q2 2015 | $251,000 | -18.2% | 30,379 | -18.4% | 0.00% | -33.3% |
| Q1 2015 | $307,000 | +91.9% | 37,229 | +59.7% | 0.00% | +50.0% |
| Q4 2014 | $160,000 | -18.4% | 23,319 | -35.8% | 0.00% | 0.0% |
| Q3 2014 | $196,000 | -55.6% | 36,345 | -47.6% | 0.00% | -60.0% |
| Q2 2014 | $441,000 | +10.5% | 69,295 | +40.0% | 0.01% | -16.7% |
| Q1 2014 | $399,000 | +221.8% | 49,492 | +171.5% | 0.01% | +200.0% |
| Q4 2013 | $124,000 | -54.1% | 18,230 | +24.3% | 0.00% | -50.0% |
| Q3 2013 | $270,000 | +5.1% | 14,670 | -0.3% | 0.00% | -20.0% |
| Q2 2013 | $257,000 | – | 14,711 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |